Lavkesh Dayashankar Kushwaha

Title: Lavkesh Dayashankar Kushwaha: Innovator in Pharmaceutical Processes

Introduction

Lavkesh Dayashankar Kushwaha is a notable inventor based in Maharashtra, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of processes for drug manufacturing. His innovative approach has led to advancements in the preparation of important pharmaceutical compounds.

Latest Patents

Kushwaha holds a patent for an industrial process for the preparation of Clopidogrel hydrogen sulphate. This improved process begins with 2-(2-thienyl) ethylamine and eliminates the need for isolating an unstable intermediate. By employing a one-pot cyclization, he successfully synthesizes 4, 5, 6, 7-tetrahydrothieno (3,2-c) pyridine. The process further involves reacting this compound with a halo-compound at controlled temperatures in a suitable solvent, which enhances the efficiency of the manufacturing process. Additionally, his invention includes a method for resolving racemic Clopidogrel into its optical antipodes and converting the dextroclopidogrel base into its known polymorphs.

Career Highlights

Kushwaha is currently associated with Ipca Laboratories Limited, where he continues to apply his expertise in pharmaceutical innovations. His work has not only contributed to the company's portfolio but has also advanced the field of drug manufacturing.

Collaborations

Kushwaha has collaborated with notable colleagues such as Ashok Kumar and Sanjay Nandavadekar. Their combined efforts have fostered a productive environment for innovation and development within the company.

Conclusion

Lavkesh Dayashankar Kushwaha exemplifies the spirit of innovation in the pharmaceutical industry. His contributions through patents and collaborative efforts have made a significant impact on drug manufacturing processes.